La capacité d'adaptation des bactéries à leur environnement repose, entre autres choses, sur des mécanismes de transduction du signal. Ces mécanismes leur permettent de percevoir la nature et les modifications du milieu dans lequel elles évoluent et d'adapter en conséquence leur métabolisme et leur physiologie. L'un de ces mécanismes identifié chez les procaryotes repose sur un processus de régulation impliquant, suite à un stimulus extérieur, une modification réversible des protéines au niveau de résidus séryles et thréonyles par phosphorylation via les sérine/thréonine protéine-kinases (STPK). Chez les bactéries pathogènes, notamment Mycobacterium tuberculosis et Staphylococcus aureus, les STPKs sont impliquées dans la régulation du métabolisme central, de la division cellulaire, de la composition de la paroi et de la virulence. Mes travaux de thèse ont eu pour objectif d'approfondir les connaissances sur la régulation post-traductionnelle des protéines via les STPKs chez ces deux pathogènes humains. Nous avons ainsi identifié de nouveaux substrats des STPKs chez M. tuberculosis et S. aureus et caractérisé l'effet de la phosphorylation sur l'activité de ces substrats. L'ensemble de mes travaux de thèse met en avant le rôle important de la régulation par les STPKs de voies métaboliques diverses chez ces deux pathogènes. / To overcome the stressful conditions imposed during host infections, pathogens have evolved various protective and offensive responses that could be achieved through cascades of phosphorylation. Many of the encountered external stimuli are transduced via sensor kinases embeded within the bacterial membrane, allowing the pathogen to adapt and survive in hostile environments. In addition to the classical two-component systems, Staphylococcus aureus and Mycobacterium tuberculosis possess eukaryotic-like Serine/Threonine Protein-Kinases (STPK). It is becoming clear that in these two human pathogens, many of the STPKs are involved in the regulation of metabolic processes, division, cell wall composition, virulence, etc. Therefore, signalling through STPK phosphorylation has recently emerged as a key regulatory mechanism in pathogenic bacteria. Thus, to investigate the mechanisms of STPK-dependent regulation in M. tuberculosis and S. aureus, we identified and characterized novel endogenous phosphorylated substrates, and analyzed the impact of phosphorylation on their specific activity. Overall, the results presented herein emphasize the important role of STPK-dependent mechanisms in various metabolic pathways in these two pathogens.

Trypanosoma brucei, parasite protozoaire flagellé appartenant à l’ordre des kinétoplastidés, est responsable de la maladie du sommeil, ou trypanosomiase humaine africaine (THA). Son cycle de vie fait intervenir un insecte vecteur hématophage (la mouche tsé-tsé ou glossine) qui lors d’un repas sanguin sur un individu infecté ingère des parasites. Après plusieurs étapes de différentiation, les parasites sont injectés à un hôte lors d’un autre repas sanguin. Nous avons étudié le métabolisme intermédiaire et énergétique de la forme procyclique de T. brucei, forme présente dans l’appareil digestif de l’insecte vecteur. Chez ce parasite, la dégradation du glucose aboutit à la production d’acétate dans l’unique mitochondrie, et de succinate dans la mitochondrie et les glycosomes, organelles spécifiques des trypanosomatidés dans lesquels la glycolyse est compartimentalisée. T. brucei utilise une "navette acétate" permettant de transférer l’acétyl-CoA produit dans la mitochondrie vers le cytosol pour initier la biosynthèse de novo des acides gras et la production d’acétate est essentielle à la croissance du parasite. La navette acétate fait intervenir dans la mitochondrie l’acétate:succinate CoA-transférase (ASCT), qui converti l'acétyl-CoA produit à partir du glucose en acétate. Nous avons identifié et caractérisé une autre enzyme mitochondriale contribuant aussi à la production d’acétate à partir du glucose : l’acétyl-CoA thioesterase (ACH). Le double mutant n’exprimant ni l’ACH ni l’ASCT ne produit plus d’acétate et n’est plus viable, confirmant le rôle essentiel de la production d’acétate. Par ailleurs, nous avons montré que l’ASCT, grâce au cycle formé avec la succinyl-CoA synthétase (SCoAS), contribue à la production d’ATP par phosphorylation au niveau du substrat dans la mitochondrie, mais l’ACH n’est pas impliqué dans la production d’ATP. La thréonine est l’acide aminé le plus rapidement consommé par le parasite et sa dégradation aboutit à la production d’acétate et de glycine. En utilisant des outils de génétique inverse et des analyses métaboliques par RMN du proton et HPTLC, nous avons caractérisé la première étape enzymatique de cette voie, catalysée par la thréonine déshydrogénase (TDH), et nous avons montré que la thréonine est la principale source de carbone pour la production d’acétate, pour la biosynthèse de novo des acides gras et des stérols. L’acétyl-CoA est produit dans la mitochondrie à partir du pyruvate provenant de la dégradation du glucose par le complexe pyruvate déshydrogénase (PDH) et à partir de la thréonine dont la dégradation est initiée par la TDH. L’acétyl-CoA provenant de la dégradation du glucose ou de la thréonine est converti en acétate par les mêmes enzymes, l’ACH et l’ASCT. Nous avons montré que la voie de dégradation de la thréonine est sous régulation métabolique. L’activité et l’expression de la TDH ainsi que la production d’acétate à partir de la thréonine sont diminuées dans le mutant knock out de la phosphoenolpyruvate carboxykinase (PEPCK) dans lequel le flux glycolytique est redirigé vers la production d’acétate. De plus, contrairement au glucose, la dégradation de la thréonine ne participe pas à la production d’ATP dans la mitochondrie du parasite. Nos résultats nous amène à l’hypothèse d’un channeling mitochondrial des voies de dégradation du pyruvate et de la thréonine pour la production d’acétate. Les trypanosomes ont développé une voie de biosynthèse de novo des acides gras faisant appel aux élongases du réticulum endoplasmique et un précurseur inhabituel, le butyryl-CoA dont la voie de biosynthèse n’est à l’heure actuelle pas connue chez les trypanosomatidés. Nous avons reconstitué une voie de biosynthèse hypothétique à partir de l’acétyl-CoA dans la mitochondrie. La dernière enzyme de cette voie, l’isovaléryl-CoA déshydrogénase (IVDH), a été caractérisée, et nos premiers résultats indiquent que cette enzyme est impliquée dans la production du butyryl-CoA. / Trypanosoma brucei, a flagellated protozoan parasite of the kinetoplastidae order, is responsible for human sleeping sickness or human african trypanosomiasis (HAT). Its life cycle is complex and involves a haematophageous insect vector (tse-tse fly or Glossina), which ingests parasites during a blood meal on an infected host. After a series of differentiations, the parasites are injected to another host during another blood meal. We studied the energy and intermediary metabolism of the procyclic form of T. brucei, which is present into the midgut of the tse-tse fly. In this parasite, glucose degradation produces acetate into the mitochondria of the parasite and succinate into both the mitochondria and the glycosomes. Glycosomes are specific organites of trypanosomatids in which the glycolysis is compartimentalized. T. brucei uses an "acetate shuttle" to transfer acetyl-CoA from the mitochondrion to the cytosol to feed de novo fatty acids biosynthesis. This acetate production is essential for cell viability. The "acetate shuttle" involves inside the mitochondrion, the acetate:succinate CoA-transferase (ASCT), which converts glucose-derived acetyl-CoA into acetate. We identified and characterised a new mitochondrial enzyme involved in acetate production from glucose, in addition to ASCT: the acetyl-CoA thioesterase (ACH). Indeed, a double mutant affecting expression of both ACH and ASCT doesn’t produce anymore acetate and is lethal, which confirms the essential role of mitochondrial production of acetate. In addition, we showed that ASCT, via the ASCT/SCoAS (succinyl-CoA synthetase) cycle, contributes to mitochondrial ATP production by substrate phosphorylation, while ACH is not involved in ATP production. We also observed that contribution of the ASCT/SCoAS cycle and oxidative phosphorylation by the mitochondrial F0-F1-ATP synthase to ATP production are similar. Threonine is the most rapidly consumed amino acid by the procyclic trypanosomes and its degradation produces acetate and glycine. Using a combination of reverse genetics, proton NMR metabolic profiling and HPTLC, we characterized the first enzymatic step of the pathway, catalysed by the threonine dehydrogenase (TDH) and showed that threonine is the main carbon source for acetate production, de novo fatty acids and sterol biosynthesis. Acetyl-CoA is produced into the mitochondrion from glucose-derived pyruvate by the pyruvate dehydrogenase complex (PDH) and by the two first steps of the threonine degradation pathway, including TDH. Both glucose-derived and threonine-derived acetyl-CoA is then converted into acetate by the same enzymes, ACH and ASCT. We also found that the threonine degradation pathway is under metabolic control. Indeed, TDH activity, TDH expression and threonine-derived acetate production are reduced in the phosphoenolpyruvate carboxykinase (PEPCK) knock out mutant, in which glycolytic flux is redirected towards acetate production. In addition, we showed that, as opposed to glucose-derived acetyl-CoA, metabolism of threonine-derived acetyl-CoA doesn’t contribute to ATP production into the mitochondrion of the parasite. Our results suggest the existence of mitochondrial metabolic channelings, which disconnect pyruvate and threonine degradation pathways leading to acetate production. Trypanosomes developed a specific de novo fatty acids biosynthesis pathway using elongases located in the endoplasmic reticulum and an unusual primer, butyryl-CoA. The biosynthesic pathway of butyryl-CoA has not been investigated so far in trypanosomatids. Genomic data mining of the T. brucei database, highlights an hypothetical mitochondrial biosynthesis pathway from acetyl-CoA to butyryl-CoA. The last enzyme of this pathway, isovaleryl-CoA dehydrogenase (IVDH), was characterised and our first results suggest that this enzyme is indeed involved into butyryl-CoA production.

Ce travail porte sur l’étude des mécanismes de phosphorylation des protéines par les sérine/thréonine kinases chez Staphylococcus aureus. Nous avons, tout d’abord, mis en évidence et caractérisé une seconde Ser/Thr-kinase, nommée Stk2. Cette kinase présente peu d’homologies avec les autres Ser/Thr-kinases bactériennes décrites à ce jour, en particulier avec la première Ser/Thr-kinase mise en évidence précédemment chez S. aureus, Stk1. Nous avons ensuite caractérisé dix sites d’autophosphorylation de Stk2 et nous avons montré que trois sites sont nécessaires à son activité. Enfin, nous avons montré que le régulateur global de virulence, SarA, est phosphorylé à la fois par Stk1 et Stk2. La phosphorylation de SarA influence sa capacité de liaison à l’ADN. Cette étude contribue à mieux appréhender, au niveau moléculaire, le rôle des Ser/Thr-kinases dans le métabolisme des bactéries et, plus particulièrement, dans la régulation de leur virulence / We report that protein phosphorylation on serine and threonine is required for controlling staphylococcal virulence. We identified and characterized a second serine/threonine kinase, Stk2, in S. aureus. Biochemical analyses revealed that this enzyme displays autokinase activity on both threonine and serine residues. Stk2 is atypical in the sense that it exhibits a weak similarity with the first Ser/Thr-kinase previously detected, Stk1, and its undergoes a different mechanism of activation compared to the other bacterial Ser/Thr-kinases described so far. We also showed that SarA, a major transcription factor that regulates more than a hundred virulence genes, is phosphorylated by both Stk1 and Stk2. Phosphorylation of SarA leads to strong effects on its ability to bind DNA. The study of Stk1 and Stk2, at the molecular level, provides a better understanding of the role of these staphylococcal Ser/Thr-kinases in bacterial metabolism and, in particular, in the regulation of virulence

A proteína serina/treonina fosfatase do tipo 1 (PP1) é a principal serina/treonina fosfatase envolvida na regulação de diversos processos tais como metabolismo, crescimento e divisão celular, síntese protéica e processamento de RNA. A holoenzima PP1 é constituída de uma subunidade catalítica conservada (PP1c) e subunidades reguladoras variáveis. Em mamíferos já foram identificados dezenas de polipeptídeos que associam-se direta ou indiretamente a PP1c, gerando holoenzimas com localizações celulares e especificidades distintas. Entre as proteínas que se associam a PP1c, muitas têm função inibitória como o inibidor-1 (I-1) e o inibidor-2 (I-2). A partir de extratos de micélios de Neurospora crassa foi purificada uma proteína, denominada INc-1, que atua in vitro como inibidor da atividade de fosforilase fosfatase de PP1c e constitui-se no primeiro exemplo de subunidade reguladora da PP1 descrito em fungos filamentosos. INc-1 apresenta diversas características bioquímicas comuns ao I-2 de mamíferos. Seqüências parciais de aminoácidos de três fragmentos proteolíticos obtidos de INc-1 permitiram a identificação de uma ORF (fase aberta de leitura) no genoma de N. crassa que provavelmente codifica INc-1. A análise dessa ORF mostrou que a sequência de aminoácidos do INc-1 é similar a do I-2, especialmente em regiões supostamente envolvidas em sua interação com a PP1c. Neste trabalho descrevemos a clonagem e a expressão em bactérias da sequência codificadora de INc-1. A atividade inibidora de PP1c de duas isoformas recombinantes purificadas, INc-1L e INc-1, foram avaliadas e comparadas. A forma denominada INc-1L apresenta em sua região aminoterminal um segmento de 38 aminoácidos derivado da retenção de um íntron, sem alterar a fase de leitura. Ambas proteínas recombinantes exibiram efeito inibidor sobre a atividade de fosforilase fosfatase de PP1c recombinante, sendo que a IC50 determinada para INc-1L foi de ~50nM e para INc-1 foi de ~11nM, sugerindo que a retenção do segmento de aminoácidos codificado pelo íntron na isoforma INc-1L diminui seu potencial inibitório. Verificamos também que o mRNA de INc-1 é expresso durante o crescimento vegetativo de N.crassa, apresentando níveis máximos na fase exponencial. / Type 1 protein serine/threonine phosphatases (PP1) play important roles in the regulation of many cellular functions including metabolism, cell growth and division, protein synthesis and pre-mRNA splicing. PP1 holoenzyme consists of one highly conserved catalytic subunit (PP1c) and variable regulatory subunits. A number of proteins that interact with PP1c have been described in mammals and the respective holoenzymes present distinct substrate specificity and/or different subcelular localization. Among the proteins that interact with PP1c, there are many with inhibitory effect such as inhibitor-1 (I-1) and inhibitor-2 (1-2). It has been demonstrated that a protein denominated INc-1, purified from Neurospora crassa extracts, specifically inhibits PP1c and has biochemical properties that resemble those of mammalian I-2. INc-1 is the first example of a PP1c regulatory subunit in filamentous fungi. Partial amino acid sequences of INc-1 led to the identification of an ORF (open reading frame) in Neurospora crassa genome which appears to encode INc-1. This ORF shows similarity with mammalian I-2 mainly in regions mapped as sites for interaction with PP1c. In this work we report the cloning and bacterial expression of the coding sequence for INc-1. The PP1c inhibitory activities of two recombinant isoforms, named INc-1L and INc-1, were compared. INc-1L aminoacid sequence presents an in frame segment of 38 residues encoded by an non-processed intron. 80th recombinant proteins showed inhibitory effect against phosphorylase phosphatase activity of recombinant PP1c, with IC50 of ~50nM for INc-1L and ~11nM for INc-1, suggesting that retention of the 38 residue segment decrease the inhibitory potential of INc-1L. We have also verified that INc-1 mRNA is expressed during N.crassa vegetative growth with maximum level at the exponential phase.

Submitted by Rosivalda Pereira (mrs.pereira@ufma.br) on 2017-06-22T19:42:13Z No. of bitstreams: 1 Ezequiel BorgesMelo.pdf: 3711016 bytes, checksum: 4169bfc0d8fb15318ce5eacdd7bda426 (MD5) / Made available in DSpace on 2017-06-22T19:42:13Z (GMT). No. of bitstreams: 1 Ezequiel BorgesMelo.pdf: 3711016 bytes, checksum: 4169bfc0d8fb15318ce5eacdd7bda426 (MD5) Previous issue date: 2015-08-21 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) / Fundação de Amparo à Pesquisa e ao Desenvolvimento Científico e Tecnológico do Maranhão (FAPEMA) / Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPQ) / Amino acids, having both the carboxylic group and amine group, may act as bidentate ligands and, depending on its radical group can also act as tridentate ligands. Amino acids complexed with transition metals have attracted the interest of chemists and physicists because of its possible applications and physical properties. L-threonine complexes with Cu+2 (Cu(II)(L-Threonine)2(H2O)), Co+2 (Co(II)(L-Threonine)2(H2O)2) e Zn+2 (Zn(II)(L-Threonine)2(H2O)2) transition metals already exist in the literature and their crystalline structures are different. However, L-threonine complexed with Ni+2 was not found in the literature. Thus, in this study, we used the amino acid L-threonine as a ligand and Ni+2 ion as the transition metal to obtain the crystal of L-threonine complexed with Ni. For that we used the Slow Evaporation crystal growth method, where a solution containing L-threonine and NiCl2.6H2O with molar ratio (2:1) and NaOH to get a basic pH, is allowed to stand for promoting the crystal growth. To get the crystal structure of this material, X-ray diffraction measures were carried in a APEX2 DUO diffractometer of the Crystallography Laboratory in the Physics Institute of UFG. The data analysis and the resolution of the structure were performed the package Bruker SHELXTL and also using the mechanism of structural determination by Direct Methods, one of the most used ways to overcome the phase problem in the structure determination of small molecules. L-threonine complexed with Ni has the chemical formula Ni(II)(L-Treonina)2(H2O)2 and crystallizes in the orthorhombic system with space group C2221. Thus, we identified that the Ni(II)(L-Treonina)2(H2O)2 crystal has a very similar crystalline structure as Co(II)(L-Treonina)2(H2O)2. Furthermore, the knowledge of the structure of this material opens up a range studies can be performed on it. / Aminoácidos, por terem tanto um grupo carboxílico como um grupo amina, podem agir como ligantes bidentados e, dependendo do seu grupo radical, podem agir também como ligantes tridentados. Aminoácidos complexados com metais de transição têm atraído o interesse de químicos e físicos devido as suas possíveis propriedade físicas e aplicações. Complexos de L-treonina com os metais de transição Cu+2 (Cu(II)(L-Treonina)2(H2O)), Co+2 (Co(II)(L-Treonina)2(H2O)2) e Zn+2 (Zn(II)(L-Treonina)2(H2O)2) já existem na literatura e os três possuem estruturas cristalinas diferentes. Entretanto, a L-treonina complexada com Ni+2 não foi encontrada na literatura. Desta forma, neste trabalho, utilizamos o aminoácido L-treonina como ligante e o íon Ni+2 como metal de transição para obter o cristal de L-treonina complexada com Ni. Para obter estes cristais, utilizamos o método de crescimento por Evaporação Lenta, onde uma solução contendo L-treonina e NiCl2.6H2O na proporção molar (2:1) mais NaOH, para deixar o pH básico, é deixada em repouso para promover o crescimento dos cristais. Para determinar a estrutura cristalina deste material, foram realizados medidas de Difração de Raios X no Difratômetro APEX2 DUO da Bruker, do Laboratório de Cristalografia do Instituto de Física da UFG. O tratamento dos dados e a resolução da estrutura foram realizados usando utilizando o pacote SHELXTL da Bruker e utilizando o mecanismo de determinação estrutural por Métodos Diretos, que é uma das alternativas mais utilizadas para contornar o problema das fases na determinação estrutural de pequenas moléculas. Com essas análises, foi determinado que a L-treonina complexada com Ni possui fórmula química Ni(II)(L-Treonina)2(H2O)2 e cristaliza na simetria ortorrômbica com grupo espacial C2221. Desta forma, identificamos que o cristal de Ni(II)(L-Treonina)2(H2O)2 tem a estrutura cristalina muito similar ao Co(II)(L-Treonina)2(H2O)2. Além disso, com o conhecimento da estrutura desse material, abre-se um leque estudos que podem ser realizados nele.

This thesis describes the target selection, cloning, expression, purification, crystallization, structure and biochemical characterization of five essential Mycobacterium tuberculosis (Mtb) proteins. The search for drugs against the causal agent of tuberculosis is urgently needed and the targeting of essential genes is necessary to fulfill this goal. The crystal structures of carbonic anhydrases (CA) Rv1284 and Rv3588c have been determined to 2.0 and 1.7 Å resolution, respectively. Rv3588c, in contrast to Rv1284, is an active β-CA that shows two different active site conformations and pH-dependent oligomerization states. Rv1295 is an active threonine synthase with an unusually high pH optimum; the structure has been solved to 2.5 Å resolution, based on which a modification to the reaction mechanism published previously is proposed. Mtb has a thick and impermeable cell envelope that constitutes an efficient barrier against drugs. One of the essential components of the envelope is mycolic acid (MA). The inhibition of enzymes participating in its synthesis would be lethal for Mtb. Rv0636, a formerly unknown-function protein has β-hydroxyacyl-ACP dehydrase activity which is essential for MA synthesis. Co-expression with partners notably improves its solubility. Around 55% of Mtb proteins have unknown function. Rv3778c is one of them and its three-dimensional structure has been determined to 1.8 Å resolution. Studies aimed at the elucidation of its biochemical function are shown. A pathway not yet reported in Mtb is also suggested.

Previous studies suggest that the IGF-I stimulates the elastin gene transcription through the unique responsive sequence on the elastin promoter, which is a putative retinoblastoma control element (RCE). This site interacts with (Sp)-family transcription factors whose delivery is mediated by the retinoblastoma protein (Rb). Since Rb (phosphorylated on serine 780) has been implicated in the initiation of the cell cycle, we speculated that a different phosphorylation of Rb might determine Rb involvement in elastogenesis. Obtained results demonstrated that, IGF-I-induced elastogenic signaling pathway in human dermal fibroblasts includes activation of cyclinE/cdk2 causing a site specific phosphorylation of Rb on threonine 821. This permits the sequestration of Sp1 by Rb before it could bind the elastin promoter, thereby allowing the elastin gene transcription. We also found that blocking of H-Ras in Costello syndrome fibroblasts (characterized by heightened proliferation and impaired elastogenesis), selectively down-regulated Rb phosphorylation on serine 780 and normalized impaired elastogenesis.

Previous studies suggest that the IGF-I stimulates the elastin gene transcription through the unique responsive sequence on the elastin promoter, which is a putative retinoblastoma control element (RCE). This site interacts with (Sp)-family transcription factors whose delivery is mediated by the retinoblastoma protein (Rb). Since Rb (phosphorylated on serine 780) has been implicated in the initiation of the cell cycle, we speculated that a different phosphorylation of Rb might determine Rb involvement in elastogenesis. Obtained results demonstrated that, IGF-I-induced elastogenic signaling pathway in human dermal fibroblasts includes activation of cyclinE/cdk2 causing a site specific phosphorylation of Rb on threonine 821. This permits the sequestration of Sp1 by Rb before it could bind the elastin promoter, thereby allowing the elastin gene transcription. We also found that blocking of H-Ras in Costello syndrome fibroblasts (characterized by heightened proliferation and impaired elastogenesis), selectively down-regulated Rb phosphorylation on serine 780 and normalized impaired elastogenesis.

Thesis (Ph.D.). / Written for the Dept. of Biology. Title from title page of PDF (viewed 2009/11/30). Includes bibliographical references.

The main focus of my PhD studies was aimed at understanding the general mechanism of nuclear translocation and isolating novel components of the nuclear translocation pathway in neurons. Using the Drosophila visual system as an in vivo model to study nuclear motility in developing photoreceptor cells (R-cells), I have identified a novel role for the Ser/Thr kinase Misshapen (Msn) and the endocytic trafficking pathway in regulating the nuclear translocation process. / The development of R-cells in the Drosophila eye disc is an excellent model system for the study of nuclear motility owing to its monolayer organization and the stereotypical translocation of its differentiating R-cell nuclei along the apical-basal plane. Prior to my thesis work, several laboratories had identified dynein and its associating proteins in R-cell nuclear translocation, however nothing was known about the signalling pathway that controlled their function in nuclear migration. Thus, one of my thesis goals was to elucidate the signalling mechanism controlling nuclear translocation in R-cells. / Using a combination of molecular and genetic approaches, I identified Msn as a key component of a novel signalling pathway regulating R-cell nuclear translocation. Loss of msn causes a failure of R-cell nuclei to migrate apically. Msn appears to control R-cell nuclear translocation by regulating the localization of dynein and Bicaudal-D (Bic-D). My results also show that Msn enhances Bic-D phosphorylation in cultured cells, suggesting that Msn regulates R-cell nuclear migration by modulating the phosphorylation state of Bic-D. Consistently, my results show that a Bic-D-phosphorylation-defective mutation disrupted the apical localization of both Bic-D and dynein. I propose a model in which Msn induces the phosphorylation of Bic-D, which in turn modulates the activity and/or subcellular localization of dynein leading to the apical migration of R-cell nuclei. / In addition to studying Msn, I have also searched for additional players in R-cell nuclear migration. From a gain-of-function approach, I found that the misexpression of the GTPase-activating-protein (GAP) RN-Tre caused a severe defect in R-cell nuclear migration. Since mammalian RN-Tre is involved in negatively regulating Rab protein activity, I speculated that the RN-Tre misexpression phenotype reflected a role for Rab-mediated vesicular transport in regulating R-cell nuclear migration. I systematically examined the potential role of Rab family proteins in R-cell nuclear migration and found that interfering with the function of Rab5, Rab11 or Shibire caused a similar nuclear migration phenotype. I propose that an endocytic pathway involving these GTPases is required for the targeting of determinants to specific subcellular locations, which in turn drive the apical migration of R-cell nuclei during development.